- April
- 16
LeCroy Corp., the Chestnut Ridge company that provides oscilloscopes, reported this morning that it earned $700,000, or 5 cents a share, during the quarter that ended in March, turning around a loss of $3.9 million, or 34 cents a share, a year earlier. Revenues were up to $40.6 million from $39.3 million.
The figures were reported on a basis that complies with general accepted accounting principles.
On a basis that doesn’t comply with those principles, LeCroy earned $2.1 million, or 17 cents a share, during the just-completed quarter, the third quarter of its fiscal 2008. A year earlier, the company earned $800,000, or 7 cents a share.
Tom Reslewic, LeCroy’s president and chief executive, said the company’s distribution of its products improved sales.
The company sells sophisticated devices that measure the strength of signals in computer chips.
Posted by Allan Drury on Wednesday, April 16th, 2008 at 1:06 pm |
Print
|
Email
| Post a Comment »
- April
- 15
Jarden Corp. said today it expects to meet or exceed earnings estimates for the first quarter.
Analysts predict the Rye-based company will earn 20 cents a share for the quarter that ended March 31, based on a consensus estimate of five analysts provided by Zacks Investment Research.
The maker of appliances and other consumer products reported net sales for the quarter of $1.2 billion, an increase of about 47 percent above the same period last year.
Jarden said its best-performing unit was its outdoor-products unit, K2, which it acquired last year. Other business segments saw a decline, it said.
Jarden products include familiar household names such as Mr. Coffee and Sunbeam appliances, Ball canning goods, and Bicycle and Bee brands of playing cards.
Jarden is scheduled to report its first-quarter earnings May 8.
Shares of the company fell 65 cents to $20.66 each in trading today.
Posted by David Schepp on Tuesday, April 15th, 2008 at 3:44 pm |
Print
|
Email
| Post a Comment »
- April
- 15
ITT Corp. of White Plains said this morning it expects its first-quarter earnings to be higher than it previously predicted.
The company, which makes pumps and night-vision goggles for the military, said the profit will be higher than 80 to 82 cents a share for the quarter that ended in March.
ITT said it also expects to earn more than the $3.80 to $3.95 a share it previously forecast for the full year. The company will report its first-quarter earnings April 25.
The company also announced that Hank Driesse, 64, is taking over leadership of its defense business on an interim basis. He replaces Steve Gaffney, 49, who has decided to leave the company to take a job at a private-equity firm.
Posted by Allan Drury on Tuesday, April 15th, 2008 at 9:15 am |
Print
|
Email
| Post a Comment »
- April
- 2
Haights Cross Communications Inc., a White Plains-based educational and library publisher, reported a net loss of $16.4 million during the fourth quarter, less than the net loss of $22.3 million a year earlier.
Revenue of $57.5 million was up 5.1 percent over a year earlier as the company benfited from growth in its test preparation, K-12 supplemental education and medical education businesses.
In January, Haights Cross said it had completed a comprehensive review of its strategic alternatives and finalized plans to offer for sale all of its business assets.
Posted by Jay Loomis on Wednesday, April 2nd, 2008 at 11:14 am |
Print
|
Email
| Post a Comment »
- March
- 17
Universal American Corp. will reduce the value of some of its sub-prime holdings by $26.7 million to account for the reduced value of the assets, which has been revised downward to their worth as of Dec. 31.
The Rye Brook-based company took the action, it said today, in agreement with its auditors, after the assets were determined to be overvalued.
The after-tax impairment was shown as an unrealized loss in the preliminary balance sheet data that Universal American presented on Feb. 19 along with its earnings release, it said.
The majority of Universal American’s subprime holdings “have been placed on negative credit watch by rating agencies,” the company said in a statement.
The company said it continues to review the estimated fair value of the securities, believing that their value will further decrease in the first quarter.
Universal American said it believes that it “will recover principal and interest greater than the market prices currently indicate.”
Posted by David Schepp on Monday, March 17th, 2008 at 5:32 pm |
Print
|
Email
| Post a Comment »
- March
- 17
Gamco Investors Inc., the money-management company run by Mario Gabelli, reported its fourth-quarter earnings dropped to $24.1 million from $27 million.
On a per-share basis, the company earned 84 cents during the quarter that ended in December, compared with 94 cents during the fourth quarter of 2006.
Assets under management — the amount of investor money the company held in its mutual and hedge funds — dropped 2 percent to $31 billion during the quarter, as the stock market sagged under the weight of a possible recession.
Posted by Allan Drury on Monday, March 17th, 2008 at 8:44 am |
Print
|
Email
| Post a Comment »
- March
- 17
Progenics Pharmaceuticals Inc., an Eastview-based company that reported last week a key experimental drug failed a late-stage clinical trial, said this morning it lost $15.3 million, or 53 cents a share, during the fourth quarter of last year. A year earlier, the company lost $1.7 million, or 7 cents a share.
Revenues dropped to $15.5 million from $21.9 million. The company’s revenues consist mainly of the reimbursements it gets for its drug research and development initiatives under a collaboration agreement with Wyeth.
The companies are seeking to develop methylnaltrexone, a treatment for patients following colon surgery. Testing on the drug is continuing.
Posted by Allan Drury on Monday, March 17th, 2008 at 8:35 am |
Print
|
Email
| Post a Comment »
- March
- 14
The Yonkers-based parent company of Hudson Valley Bank yesterday restated certain financial statements for 2005, 2006, and the first three quarters of 2007, but it said the changes would not affect figures on profits, net interest income, assets or shareholders’ equity.
In a filing with the Securities and Exchange Commission, Hudson Valley Holding Corp. said the changes affected the statements of cash flows involving operating and investing activities. It said the errors resulted from misclassification of changes in bank-owned life insurance, goodwill, and intangible assets as operating cash flows rather than investment cash flows.
In a separate filing, Hudson Valley Holding reported 2007 annual earnings rose 1.2 percent to $34.5 million, or $3.39 a share, from $34.1 million, or $3.35 a share, in 2006.
Net interest income rose 2.5 percent to $104.1 million last year from $99.6 million in 2006, and total assets rose 2 percent to $2.33 billion from $2.29 billion in 2006.
The company filed the reports after stock markets closed this afternoon. In trading today, the company’s stock rose 50 cents to $59.75 a share.
Posted by Jerry Gleeson on Friday, March 14th, 2008 at 5:20 pm |
Print
|
Email
| Post a Comment »
- March
- 14
IntegraMed America Inc., the Purchase-based company that runs fertility centers and vein clinics, earned $3.26 million last year, a 1-percent gain from 2006, the company disclosed in a regulatory filing.
On a per-share basis, earnings were flat at 39 cents a share. Revenues for the year rose 20.3 percent to $152 million from $126.4 million in 2006, according to the Securities and Exchange Commission filing.
Shares of the company ended trading today up 81 cents a share to $9.85 each.
Posted by David Schepp on Friday, March 14th, 2008 at 4:57 pm |
Print
|
Email
| Post a Comment »
- March
- 13
Higher stock-based compensation helped drive up the fourth-quarter loss at Hudson Technologies Inc., a Pearl River-based company that decontaminates large refrigeration equipment.
The company reported this morning it lost $986,000, or 5 cents a share, during the quarter that ended in December, compared with a loss of $110,000, or less than a penny a share, a year earlier.
The company said revenues were $2.73 million, a drop from the $2.77 million in the last quarter of 2006.
Kevin J. Zugibe, the chairman and chief executive, said the loss from the most-recently completed quarter included a non-cash $437,000 share-based compensation expense, higher interest expense on increased debt related to the 2007 stock repurchases, and additional taxes.
“Absent the non-cash expenses, the cash flow of the business remains very strong,” he said.
Posted by Allan Drury on Thursday, March 13th, 2008 at 8:44 am |
Print
|
Email
| Post a Comment »
- March
- 6
TAL International Group Inc. of Purchase, a lessor of freight containers and chassis, said yesterday that it had lower fourth-quarter profits on higher revenues.
The company reported net income of $3.4 million, or 10 cents a share, on revenue of $91.4 million. For the comparable quarter a year earlier, it had net income of $14.9 million. or 45 cents a share, on revenue of $79 million. Unrealized losses on interest rate swaps boosted the expense line last quarter.
For 2007, TAL had net income of $38.8 million, or $1.16 a share, on revenue of $343.3 million. For 2006, it had net income of $42.1 million, or $1.26 a share, on revenue of $305.6 million.
Posted by Jerry Gleeson on Thursday, March 6th, 2008 at 6:22 pm |
Print
|
Email
| Post a Comment »
- March
- 6
Presidential Life Corp. of Nyack reported lower fourth-quarter profits but higher profits for the year.
The company had net income last quarter of $4 million, or 14 cents a share. For the comparable quarter a year earlier, it had net income of $7.93 million, or 27 cents a share.
For 2007, it had net income of $63.7 million, or $2.16 a share. For 2006, it had net income of $49.7 million, or $1.69 a share.
Revenue figures were not released.
Posted by Jerry Gleeson on Thursday, March 6th, 2008 at 6:21 pm |
Print
|
Email
| Post a Comment »
- March
- 5
Jarden Corp., the consumer products company based in Rye, expects to reach its goal of $3 in earnings per share from continuing operations this year, Chief Executive Officer Martin E. Franklin told analysts this week.
The result is at the low end of the three-to-five year time frame that it targeted in January 2005 to reach the $3 goal. Franklin said the company still plans to achieve $5 in earnings per share from continuing operations by 2011.
Posted by Jerry Gleeson on Wednesday, March 5th, 2008 at 6:05 pm |
Print
|
Email
| Post a Comment »
- March
- 4
BioScrip Inc. of Elmsford, a specialty pharmaceutical healthcare business, today reported higher fourth-quarter profits and revenues.
BioScrip had net income of $2.52 million, or 6 cents a share, on revenue of $309.2 million. For the comparable quarter a year earlier, it had a net loss of $28 million, or 75 cents a share, on revenue of $292.1 million.
The company said it set up a $25.7 million reserve in the earlier quarter.
For fiscal 2007, BioScrip had net income of $3.32 million, or 9 cents a share, on revenue of $1.2 billion. For fiscal 2006, it had a net loss of $38.3 million, or $1.03 a share, on revenue of $1.15 billion.
Posted by Jerry Gleeson on Tuesday, March 4th, 2008 at 5:37 pm |
Print
|
Email
| Post a Comment »
- February
- 28
Barr Pharmaceuticals Inc., the company with research operations in Pomona, earned $32.5 million, or 30 cents a share, during the fourth quarter of last year.
Revenues were $668.7 million, the company reported this morning.
In the fourth quarter of calendar year 2006, Barr, the parent company of Rockland-based Barr Laboratories Inc., changed its fiscal year to end on Dec. 31 instead of June 30. Also, in October 2006, Barr bought Pliva d.d., a Croatian generics pharmaceutical company, for $2.4 billion.
Because of these two moves, the comparison of year-to-year figures is not meaningful, the company said.
Barr shares rose 50 cents yesterday to close at $49.19.
Posted by Allan Drury on Thursday, February 28th, 2008 at 8:55 am |
Print
|
Email
| Post a Comment »
- February
- 27
Regeneron Pharmaceuticals, which has its headquarters in Eastview, lost $13.1 million during the fourth quarter of last year, compared with a loss of $31 million a year earlier, the company reported this morning.
On a per-share basis, the company lost 19 cents a share, compared with 51 cents in the fourth quarter of 2006.
Revenues rose to $64.73 million, from $10.25 million.
Regeneron shares closed at $18.46 yesterday, down 20 cents.
The company announced in November it would receive an $85 million upfront payment from French pharmaceutical company Sanofi-Aventis SA as part of an agreement to develop therapeutic antibodies for arthritis and cancer.
Regeneron and Bayer HealthCare AG are working on a treatment for eye disease in the elderly.
Posted by Allan Drury on Wednesday, February 27th, 2008 at 9:52 am |
Print
|
Email
| Post a Comment »
- February
- 25
Spar Group Inc., a marketing company in Greenburgh, earned $1.5 million, or 8 cents a share, during the fourth quarter of last year, compared with a loss of $105,000, or a penny a share, a year earlier, the company reported this morning.
Revenues rose 16 percent to $18.4 million from $15.8 million, the company said.
Gary Raymond, the company’s president and chief executive, said Spar’s international revenue is growing strongly and the company has just begun executing a strategy to increase its U.S. revenue.
“As the world retail market becomes increasingly competitive we see many opportunities in the near and long term for our services to help existing and potential clients differentiate themselves in crowded retail markets,” he said.
Posted by Allan Drury on Monday, February 25th, 2008 at 9:16 am |
Print
|
Email
| Post a Comment »